abstract |
Provided is a drug for the prevention and treatment of prostaglandin D-mediated diseases and symptoms. A hematopoietic prostaglandin D synthase (H-PGDS) inhibitor comprising a multiheteroaryl compound represented by the following formula (II). [Selection figure] None |